Smith & Nephew (SNN) Research & Development (2009 - 2024)

Smith & Nephew (SNN) posted quarterly Research & Development of -$137.0 million for Q4 2024, up 17.47% year-on-year from -$116.6 million in Q1 2024, and up 17.47% on a QoQ basis from -$166.0 million in Q4 2023.

Smith & Nephew (SNN) Research & Development (2009 - 2024) Analysis & Trends

Smith & Nephew (SNN) has reported Research & Development for 16 consecutive years, with -$137.0 million the latest figure, recorded in Q4 2024.

  • Quarterly Research & Development rose 17.47% year-over-year to -$137.0 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was -$648.0 million (up 1.67% YoY) and the FY2025 annual result came in at $296.0 million, up 2.42% from the prior year.
  • Research & Development improved to -$137.0 million in Q4 2024 per SNN's latest filing, from -$166.0 million in the prior quarter.
  • Over the last five years, Research & Development for SNN reached as high as -$137.0 million in Q4 2024 and fell as low as -$174.0 million in Q4 2022.
  • A 5-year average of -$159.2 million and a median of -$166.0 million in 2023 frame the typical range for Research & Development.
  • Annual changes were most pronounced in 2020 — Research & Development surged 49.32% — and 2021, when it retreated 15.54%.
  • Year by year, Research & Development stood at -$148.0 million in 2020, then slipped by 15.54% to -$171.0 million in 2021, then slipped by 1.75% to -$174.0 million in 2022, then rose by 4.6% to -$166.0 million in 2023, then climbed by 17.47% to -$137.0 million in 2024.
  • According to Business Quant data, Research & Development over the past three periods registered -$137.0 million, -$166.0 million, and -$174.0 million for Q4 2024, Q4 2023, and Q4 2022 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 767.00 Mn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 413.00 Mn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 671.00 Mn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 516.00 Mn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 263.30 Mn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 145.30 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn -461.27 Mn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 345.00 Mn
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Steris 20.59 Bn 20.16 Bn 697.10 Mn 28.80 Mn

Historic Data

Download Data
DateValue
Dec 31, 2024 -137.00 Mn
Dec 31, 2023 -166.00 Mn
Dec 31, 2022 -174.00 Mn
Dec 31, 2021 -171.00 Mn
Dec 31, 2020 -148.00 Mn
Dec 31, 2019 -292.00 Mn
Dec 31, 2018 -246.00 Mn
Dec 31, 2017 -223.00 Mn
Dec 31, 2016 -230.00 Mn
Dec 31, 2015 -222.00 Mn
Dec 31, 2014 -235.00 Mn
Sep 30, 2014 -57.00 Mn
Mar 31, 2014 -58.00 Mn
Dec 31, 2013 -231.00 Mn
Mar 31, 2013 -62.00 Mn
Dec 31, 2012 -171.00 Mn
Jun 30, 2012 -39.00 Mn
Mar 31, 2012 -46.00 Mn
Dec 31, 2011 -167.00 Mn
Sep 30, 2011 -126.00 Mn